Investor Ideas #Potcasts 532, #Cannabis News and #Stocks on the Move; Interview with Paul Rosen, CEO of 1933 Industries (CSE: $TGIF.C) (OTC: $TGIFF)
Delta, Kelowna, BC, February 18, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/02181TGIF-Interview.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast Investorideas interviews Paul Rosen, CEO of 1933 Industries (CSE: TGIF) (OTC: TGIFF), where we discussed the current trends surrounding the cannabis industry, current investor sentiment, what are the current expectations surrounding regulatory reform in the US and how 1933 Industries\ home market of Nevada is expected to grow and evolve moving forward.
Paul Rosen is a noted career entrepreneur, management consultant and public speaker. Over the last 8 years Paul has become one of the most active entrepreneurs, advisors and investors in the emerging global cannabis industry. Paul Rosen was a co-founder of PharmaCan Capital Corp. (Now Cronos Group Inc.) (NASDAQ: CRON) (TSX: CRON) and served as its first President and CEO. Paul has held board positions with a number of publicly-traded cannabis companies and currently serves as the Executive Chairman of Global Go, a consultancy focused on the global regulated cannabis industry.
Paul has enjoyed a distinguished speaking and media career. He has appeared on/in Bloomberg, CNN, CNBC, Fox Business, BBC Business, Nasdaq TV, Yahoo Finance, The Economist, The Street, Barrons, National Public Radio and Cheddar TV. Paul is a member of the Law Society of Upper Canada and received a B.A. in Economics from Western University in 1985 and an LL.B. from the University of Toronto in 1988.
Since January, cannabis stocks have seen a flourish of positive trading and investor sentiment, in part due to a trend of positive financial results as well as high expectations surrounding the Democratic majority hopefully pushing more cannabis regulatory reform.
When asked about the current optimism surrounding the cannabis industry today Mr. Rosen commented, “my optimism was never misplaced. Cannabis is a young industry that has already gone through operatic cycles of peaks and pull backs which is typically expected of an early stage industry, but what we should say is the “thesis”around Cannabis has only gone in one direction and that’s straight up. We have to separate the day to day fickleness of investor sentiment with what’s actually happening with the economy of cannabis, and what’s happening the economy of cannabis is month after month sales growth, almost without interruption. I think you can look back on those barrish periods and look at them as buying opportunities, I know I did. I never doubted at a macro level that the industry was under any distress, individual companies were under distress, but the industry has been performing even above most optimistic projections.”
Mr Rosen continued, “There is now an almost irrevocable momentum towards cannabis reform at a global level. We’re going to look back at today’s cannabis economy a decade from now and realize how small it still was. The so-called once in a lifetime opportunity is a chance to help build an industry that inevitably is going to attract the attention and potential market weight of big pharma and big CPG, but to be able to build defendable assets before that happens writ large.”
When asked some of the advantages surrounding the US cannabis industry, and specifically Nevada, Mr. Rosen commented, “I like Nevada a lot from the macroeconomic perspective. Nevada has been a market where the cannabis control board has been more discretionary in the granting of licenses and less administrative. So on the supply demand economics it was a limited supply state and when you introduce the velocity of tourism, in a regular pre-COVID economy, it had a remarkable demand. One thing we’ve learned during COVID was that Nevada was not as dependent on the tourism market as we had though, there is a very healthy domestic market there, but once tourism comes back it comes back to supply and demand. Let’s say tourism returns to normal 6 months from now, which is going to more than double the total addressable market, there won’t be a two-times response in available capacity.”
|Mr. Rosen went on to comment on the speculation surrounding legalization in the US saying, “I predict, and I am far from alone in this, this a consensus point of thought leaders in our industry, that we will see a series of incremental congressional initiatives succeed in this congress in the next 24 months before midterms. We all know these acronyms like they’re the names of our pets; the SAFE Act, MORE Act and STATES Act. Exactly which os those congressional initiatives passed first? I hope it’s the SAFE Act, because the banking act would be the most transformative as one single piece of legislation for the development of the industry. Any one of them would have the same effect, it’s just the effect would be more pronounced with SAFE. As to legalization, well it’s coming, but the question is what it’s going to look like? The question to drill down to is where is cannabis going to show up on the Schedule on the controlled substances act? If I could have my druthers I would say deschedule cannabis, take it right out the controlled substances act, pass those legislations and reap the benefits of a dynamic industry that favours nearly every constituency and causes little to no social harm.”
Mr. Rosen went on to discuss the expected clarification from the FDA surrounding the CBD industry in the US, how the WallStreetBets community has recently focussed on the cannabis sector, synthesis versus full and partial spectrum products, the emergence of psychedelics and what investors and consumers should look forward to in the cannabis industry in 2021 and beyond.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory